Adipokines protecting CKD | Zendy

Satoshi Miyamoto | Zendy; Kumar Sharma | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adipokines protecting CKD

Author(s) -

Satoshi Miyamoto,

Kumar Sharma

Publication year - 2013

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gft261

Subject(s) - adipokine , medicine , kidney disease , endocrine system , pathogenesis , disease , adipose tissue , diabetes mellitus , bioinformatics , endocrinology , hormone , insulin resistance , biology

Increasing incidence of chronic kidney disease (CKD) which leads to end-stage renal disease (ESRD) is one of the major health issues in the modern world and requires novel strategies for treatment. Adipose tissue has been recognized to have endocrine function and secretes a variety of hormones called adipokines. Several adipokines have been implicated in the pathogenesis of CKD and may have a strong impact as a risk factor for renal decline. The aim of this review is to provide an overview of the role of adipokines in the progression of CKD, with focus on recent experimental and clinical advances.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research